University of Alabama at Birmingham
Birmingham, Alabama, 35223-1517, United States
NCT Number: NCT07157293
Participants will complete one online intervention lasting 12 weeks. Each week, they will be asked to complete a 20-30 minute session online. The intervention is targeting improved mood and positive affect in order to support increases in motivation and goal-directed behavior. Before and after the intervention, participants will be asked to complete measures to assess symptoms, mood, and behavior.
Trial opening soon.
Get Notified18 year–65 year
All sexes
Interventional
Not applicable
Birmingham, Alabama, 35223-1517, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This is a online intervention that will ask participants to review and complete 30 minutes of material each week.
Time frame: immediately before and after the intervention
Interview measure of motivation and pleasure
Contact information is provided by the study sponsor or research team.
University of Alabama at Birmingham
Other
An Online Intervention To Enhance Motivation and Goal-Directed Behavior
Acronym: Online Mot
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03525054
Diagnosis, Psychiatric, Mental Disorders
Brest, France
View Trial DetailsNCT04902066
Behavior, Behavioral Symptoms
Copenhagen, Hellerup, Denmark
View Trial DetailsNCT07446569
Early Psychosis, Mental Disorders
Bron, France
View Trial DetailsNCT05340348
Mental Disorders, Neurodevelopmental Disorders
Brest, France
View Trial Details